The independent source for health policy research, polling, and news.
1,501 - 1,520 of 1,672 Results
With Republicans in control of Congress and the White House, HSAs — a longtime favorite of conservatives — are likely to get a boost.
President-elect Donald Trump says his administration will offer its plan to overhaul the federal health law once Rep. Tom Price is confirmed as the secretary of the Department of Health and Human Services.
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
New research finds that the Affordable Care Act — especially the Medicaid expansion — helped about 4 million people with chronic health problems get coverage. Researchers say their findings could help Republicans planning a replacement.
With the most expensive medical care and health insurance premiums in the nation, Alaska seeks a novel way to bail out Obamacare.
Remarks by Sen. Mike Lee and Reps. Jim Jordan and Mark Meadows reflect growing uncertainty about Republicans’ path to overhaul Obamacare.
President Barack Obama succeeded where many other presidents failed, but now the fate of the Affordable Care Act rests with President-elect Donald Trump.
One in four doctors practicing in the U.S. is an international medical doctor. Many foreign-born doctors practice in parts of the country where there are doctor shortages.
The medical supply industry makes a particularly revelatory case study of the difficulties of untangling global trade.
An aging writer discovers there are worse things than going bald after examining the side effects of a popular hair loss drug purportedly used by President Donald Trump.
Is Republican Rep. Mark Meadows the man who would kill "Trumpcare"? He enjoys strong support in his gerrymandered western North Carolina district as he leads conservative opposition to the GOP’s plan for repealing and replacing Obamacare.
Teachers and health professionals report post-election depression, anxiety and stress in young immigrants and minorities.
The prospect of repealing the Affordable Care Act – with no replacement ready – finds many having second thoughts.
Stephanie Armour of The Wall Street Journal, Alice Ollstein of Politico and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss the suggested cuts to health programs in President Donald Trump’s budget proposal, the latest on lawsuits challenging work requirements for Medicaid enrollees and the FDA’s crackdown on e-cigarettes. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.
The legislation is only a first step, declaring the “intent” of the state Senate without specifics or a timetable.
After intense negotiations among party factions, Republican leaders unveil legislation that committees will mark up this week.
Amplifying the "patient voice," those with the rarest afflictions are trained to become powerful advocates for new drugs and legislation that would help the industry.
A drug from Marathon Pharmaceuticals has ignited a firestorm on Capitol Hill and beyond. What makes it different than the $750,000 drug that came before it?
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
People who think the change in administrations may save them from having to pay a fine for not having insurance in 2016 could be in for a rude surprise.
© 2026 KFF